RMD|Analyst Targets
RMD|Company Info
RMD|Insider Trading
RMD|Fundamentals
RMD|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'27 | $2.67 | - | - |
| Q4'26 | $2.92 | $2.95 | +1.1% |
| Q3'26 | $2.80 | $2.86 | +2.2% |
| Q3'25 | $2.50 | $2.55 | +2.1% |
| Q2'25 | $2.48 | $2.55 | +2.8% |
| Q1'25 | $2.36 | $2.37 | +0.4% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'27 | $1.4B | - | - |
| Q4'26 | $1.5B | $1.5B | -0.7% |
| Q3'26 | $1.4B | $1.4B | +0.6% |
| Q3'25 | - | $1.3B | - |
| Q2'25 | - | $1.3B | - |
| Q1'25 | - | $1.3B | - |
RMD|Monthly Returns
Market Data
RMD Stock Snapshot
- Market cap
- 33.05B
- P/E ratio
- 21.7
- Day range
- $232.76 – $237.06
- News sentiment
- 53/100 · Neutral
- Analyst target
- $250.52 (+6.5%)
- Consensus
- Hold · 27 analysts
RMD is on the weaker side of its setup, with little confirmation for a reversal yet. Earnings and guidance carry more weight than macro data at this capitalisation.
Reverse DCF
What growth is priced into RMD?
At today's price, ResMed Inc. needs to grow free cash flow about 6.7% a year for the next 10 years to justify its valuation at a 8.60% cost of capital. Over its actual history it has compounded free cash flow at 12.6% a year, so the market is asking for 5.8 percentage points below its own delivered rate. On that basis RMD looks priced below what its own growth record supports.
- Implied FCF growth
- 6.7%
- Historical FCF CAGR
- 12.6%
- Growth gap
- -5.8 pts
- Verdict
- CHEAP
- Discount rate (WACC)
- 8.60%
- Beta
- 0.69
Behaviour On Record
What RMD's own history says about today's numbers
- Realized volatility (21d)
- 17.9% 22nd pct
- Below its peak
- -21.0%
- vs 200-day average
- +4.4%
- Up days (1y)
- 48%
ResMed Inc. is currently running 17.9% annualised volatility over the last 21 sessions. Measured against RMD's own 13 years of daily returns rather than a market-wide average, that is the 22nd percentile — unusually subdued by its own history, against a typical reading of 24.1%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
RMD is trading -21.0% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -19.5%, and the deepest was -44.1% in 2023. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits +4.4% from its 200-day moving average. Against every other day in its history, that gap ranks at the 45th percentile — close to the gap it normally carries. Over the past year RMD closed higher on 48% of sessions, and it is currently 5 sessions into a rising streak.
On October specifically: over 13 years of records, RMD finished the month higher 7 of 13 times, with a median return of +0.3% and an average of +1.7%. Its strongest month historically has been July at +5.9% on average, its weakest September at -2.6%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: RMD has opened more than 2% away from the prior close in 121 of 3,267 sessions (3.7% of the time), with the largest gaps running +10.4% and -9.2%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
All figures computed from 3,268 daily closes between 2013-10-15 and 2026-10-13, split-adjusted, recomputed daily. Percentiles are against RMD's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of RMD's sector?
ResMed Inc. sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading).
- Sector rank
- #2 of 12
- Sector state
- Leading
- Sector rotation score
- 82
Analyst Rating Changes
Are analysts turning bullish or bearish on RMD?
RBC Capital most recently upgraded ResMed Inc. to Outperform on Sep 15, 2026 with a price target of $262 (from $244). Over the last 90 days, coverage has run 1 upgrade against 0 downgrades, a net bullish lean.
- Latest action
- RBC Capital — Outperform
- 90-day upgrades
- 1
- 90-day downgrades
- 0
- Net rating momentum
- +1
Peers & ETF holders
RMD peers & ETF holders
Medical Instruments & SuppliesMarket cap · today
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Vanguard Group Inc | ▼ Sell | 18,882,403 | 13.41% | $4.55B | 2026-01-29 |
| BlackRock, Inc. | ▲ Buy | 12,317,194 | 8.75% | $2.40B | 2026-08-07 |
| Geode Capital Management, LLC | ▼ Sell | 4,352,320 | 3.09% | $845.16M | 2026-08-12 |
| Invesco Ltd. | ▲ Buy | 2,063,578 | 1.47% | $402.15M | 2026-08-14 |
| Morgan Stanley | ▼ Sell | 1,928,931 | 1.37% | $375.91M | 2026-08-13 |
| Northern Trust Corp | ▼ Sell | 1,696,674 | 1.21% | $330.65M | 2026-08-13 |
| Goldman Sachs Group Inc | ▲ Buy | 1,160,426 | 0.82% | $226.14M | 2026-08-14 |
| AQR Capital Management LLC | ▲ Buy | 910,623 | 0.65% | $177.14M | 2026-08-14 |
| JPMorgan Chase & Co | ▲ Buy | 833,536 | 0.59% | $165.40M | 2026-08-12 |
| Bank of America Corp | ▼ Sell | 775,424 | 0.55% | $151.11M | 2026-08-14 |
| Citigroup Inc | ▲ Buy | 774,425 | 0.55% | $150.92M | 2026-08-03 |
| Norges Bank | ▼ Sell | 664,714 | 0.47% | $129.54M | 2026-08-12 |
| AllianceBernstein L.P. | ▲ Buy | 491,472 | 0.35% | $110.33M | 2026-08-14 |
| Citadel Advisors LLC | ▲ Buy | 508,284 | 0.36% | $99.05M | 2026-09-02 |
| Two Sigma Investments, LP | ▲ Buy | 411,036 | 0.29% | $80.10M | 2026-08-14 |
| Wells Fargo & Company | ▲ Buy | 230,914 | 0.16% | $45.00M | 2026-08-14 |
| FMR LLC (Fidelity) | ▼ Sell | 216,630 | 0.15% | $42.22M | 2026-08-13 |
| Millennium Management LLC | ▲ Buy | 204,731 | 0.15% | $39.90M | 2026-08-14 |
| Man Group plc | ▲ Buy | 126,291 | 0.09% | $24.61M | 2026-08-14 |
| Gotham Asset Management, LLC | ▼ Sell | 82,828 | 0.06% | $16.14M | 2026-08-14 |
| Wellington Management Group LLP | ▲ Buy | 81,184 | 0.06% | $15.82M | 2026-08-14 |
| Prudential Financial Inc | ▼ Sell | 74,767 | 0.05% | $14.57M | 2026-08-12 |
| Susquehanna International Group, LLP | ▲ Buy | 71,754 | 0.05% | $13.98M | 2026-08-14 |
| Bridgewater Associates, LP | ▲ Buy | 67,381 | 0.05% | $13.13M | 2026-08-14 |
| Fisher Asset Management, LLC | ▼ Sell | 52,511 | 0.04% | $10.23M | 2026-08-04 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Alan Armstrong | Senate | OK | ▲ Buy | $1K - $15K | 2026-03-27 | 2026-07-21 |
| Kelly Louise Morrison | House | MN03 | ▼ Sell | $1K - $15K | 2025-06-04 | 2025-06-18 |
| Kelly Louise Morrison | House | MN03 | ▼ Sell | $1K - $15K | 2025-04-28 | 2025-05-13 |
| Rob Bresnahan | House | PA08 | ▼ Sell | $1K - $15K | 2025-01-13 | 2025-02-13 |
| Tommy Tuberville | Senate | AL | ▼ Sell | $1K - $15K | 2024-05-03 | 2026-08-05 |
| Tommy Tuberville | Senate | AL | ▲ Buy | $1K - $15K | 2023-10-17 | 2023-11-16 |
| Tommy Tuberville | Senate | AL | ▼ Sell | $1K - $15K | 2022-10-05 | 2022-11-10 |
| Tommy Tuberville | Senate | AL | ▲ Buy | $1K - $15K | 2022-03-30 | 2022-04-08 |
| Tommy Tuberville | Senate | AL | ▼ Sell | $1K - $15K | 2021-10-26 | 2021-11-10 |